| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2020 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President | Sell | 20,000 | $12.71 | $254,200.00 | -8.2% | |
| Jan 23, 2020 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Director | Sell | 60,000 | $12.59 | $755,400.00 | -9.8% | |
| Jan 23, 2020 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 20,000 | $52.12 | $1,042,398.00 | +0.5% | |
| Jan 22, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 167,595 | $0.34 | $57,273.90 | - | |
| Jan 21, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 3,990 | $20.07 | $80,070.52 | -4.8% | |
| Jan 21, 2020 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 295,287 | $21.93 | $6,476,863.08 | -54.5% | |
| Jan 21, 2020 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 15,329 | $139.81 | $2,143,114.58 | -34.5% | |
| Jan 16, 2020 | EBS Emergent Biosolutions Inc. | Harsanyi Zsolt | Director | Sell | 3,435 | $55.00 | $188,925.00 | -8.7% | |
| Jan 16, 2020 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Director | Sell | 8,888 | $12.80 | $113,766.40 | -1.6% | |
| Jan 15, 2020 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 25,000 | $42.68 | $1,066,968.25 | -85.1% | |
| Jan 15, 2020 | ZTS Zoetis Inc. | Trawicki Roman48 | Executive Vice President | Sell | 2,199 | $137.41 | $302,164.59 | -100% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Sellers Bakari T. | Director | Buy | 10,000 | $1.00 | $10,000.00 | +395.1% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Morris Gregory C | Director | Buy | 15,000 | $1.00 | $15,000.00 | +592.7% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Coffman Raymond Scott | Co-ceo | Buy | 125,000 | $1.00 | $125,000.00 | +1.0% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Sumichrast Martin A.83 | Co-ceo | Buy | 125,000 | $1.00 | $125,000.00 | +46.2% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Ghiloni Peter J. | Director | Buy | 125,000 | $1.00 | $125,000.00 | +83.3% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Elliott Mark S | CFO &COO | Buy | 15,000 | $1.00 | $15,000.00 | +47.3% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Stephen Scott G. | Director | Buy | 20,000 | $1.00 | $20,000.00 | +95.0% | |
| Jan 14, 2020 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 1,321 | $23.87 | $31,532.27 | -3.6% | |
| Jan 14, 2020 | YCBD Cbdmd, Inc. | Raines William F III | Director | Buy | 20,000 | $1.00 | $20,000.00 | +21.3% | |
| Jan 13, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 100,000 | $16.40 | $1,639,770.09 | -0.7% | |
| Jan 13, 2020 | MRK Merck & Co., Inc. | Gerberding Julie L. | EVP Strat Comm, Gi Pub Policy | Sell | 102,073 | $89.34 | $9,118,864.98 | -73.4% | |
| Jan 13, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $138.92 | $28,478,495.47 | - | |
| Jan 10, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 210,000 | $138.00 | $28,979,013.00 | -0.2% | |
| Jan 9, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 220,000 | $135.79 | $29,874,728.52 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.